Top compounds associated with response to LRRC9


Feature Type Standardized
Nominal ANOVA
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.04 0.2
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.039 0.2
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.045 0.2
mRNA AZD8055 CTRPv2 pan-cancer AAC -0.042 0.2
mRNA VER-155008 CTRPv2 pan-cancer AAC -0.043 0.2
mRNA NVP-ADW742 CTRPv2 pan-cancer AAC 0.041 0.2
mRNA ELCPK CTRPv2 pan-cancer AAC 0.059 0.2
mRNA birinapant CTRPv2 pan-cancer AAC -0.045 0.2
mRNA OSI-027 CTRPv2 pan-cancer AAC -0.041 0.2
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.033 0.2
Download CSV